TY - JOUR
T1 - Chronic Lung Disease and Mortality after Cardiac Surgery
T2 - A Prospective Cohort Study
AU - Ponomarev, Dmitry
AU - Kamenskaya, Oksana
AU - Klinkova, Asya
AU - Loginova, Irina
AU - Vedernikov, Pavel
AU - Kornilov, Igor
AU - Shmyrev, Vladimir
AU - Lomivorotov, Vladimir
AU - Chernavskiy, Aleksander
AU - Karaskov, Aleksander
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/10
Y1 - 2018/10
N2 - Objective: To investigate the 1-year survival in cardiac surgical patients with lung disease, including previously undiagnosed cases. Design: Prospective cohort study. Setting: Tertiary hospital. Participants: Patients scheduled for elective coronary artery bypass graft (CABG) surgery. Interventions: None. Measurements and Main Results: Pulmonary function tests (PFTs) were performed in 454 patients before surgery. Abnormal respiratory patterns were defined as follows: obstructive (forced expiratory volume in 1 second/forced vital capacity <0.70), restrictive (forced expiratory volume in 1 second/forced vital capacity ≥0.70 and forced vital capacity <80% of predicted), and mixed. Overall 1-year mortality was 3.3%. Among 31 patients with documented chronic obstructive pulmonary disease (COPD), mortality was 9.6%, hazard ratio (HR) 1.28, 95% confidence interval (CI) 1.02-12.80, p = 0.04. Of 423 patients without history of COPD, 57 obstructive, 46 restrictive, and 4 mixed abnormal patterns were identified. Of a total of 72 with obstructive lung disease confirmed by PFT (ie, 15 of COPD patients and 57 newly identified cases), 6.9% died, HR 2.75, 95% CI 0.98-8.07, p = 0.06. When combined with cases of COPD where a respiratory abnormality was confirmed (26 patients), newly diagnosed obstructive lung disease (57 patients) was significantly associated with 1-year mortality, HR 4.13, 95% CI 1.50-11.42, p = 0.006. The adjustment for EuroSCORE II did not change the results. Conclusions: Combination of confirmed preexisting lung disease and newly diagnosed cases provides a clear link to mid-term mortality.
AB - Objective: To investigate the 1-year survival in cardiac surgical patients with lung disease, including previously undiagnosed cases. Design: Prospective cohort study. Setting: Tertiary hospital. Participants: Patients scheduled for elective coronary artery bypass graft (CABG) surgery. Interventions: None. Measurements and Main Results: Pulmonary function tests (PFTs) were performed in 454 patients before surgery. Abnormal respiratory patterns were defined as follows: obstructive (forced expiratory volume in 1 second/forced vital capacity <0.70), restrictive (forced expiratory volume in 1 second/forced vital capacity ≥0.70 and forced vital capacity <80% of predicted), and mixed. Overall 1-year mortality was 3.3%. Among 31 patients with documented chronic obstructive pulmonary disease (COPD), mortality was 9.6%, hazard ratio (HR) 1.28, 95% confidence interval (CI) 1.02-12.80, p = 0.04. Of 423 patients without history of COPD, 57 obstructive, 46 restrictive, and 4 mixed abnormal patterns were identified. Of a total of 72 with obstructive lung disease confirmed by PFT (ie, 15 of COPD patients and 57 newly identified cases), 6.9% died, HR 2.75, 95% CI 0.98-8.07, p = 0.06. When combined with cases of COPD where a respiratory abnormality was confirmed (26 patients), newly diagnosed obstructive lung disease (57 patients) was significantly associated with 1-year mortality, HR 4.13, 95% CI 1.50-11.42, p = 0.006. The adjustment for EuroSCORE II did not change the results. Conclusions: Combination of confirmed preexisting lung disease and newly diagnosed cases provides a clear link to mid-term mortality.
UR - http://www.scopus.com/inward/record.url?scp=85040358714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040358714&partnerID=8YFLogxK
U2 - 10.1053/j.jvca.2017.12.016
DO - 10.1053/j.jvca.2017.12.016
M3 - Article
C2 - 29336961
AN - SCOPUS:85040358714
SN - 1053-0770
VL - 32
SP - 2241
EP - 2245
JO - Journal of cardiothoracic and vascular anesthesia
JF - Journal of cardiothoracic and vascular anesthesia
IS - 5
ER -